Lycefoxim Tablet contains Cefuroxime 500mg, a second-generation cephalosporin antibiotic effective against a broad spectrum of gram-positive and gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and sinusitis. Cefuroxime exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The drug demonstrates stability against beta-lactamase enzymes produced by certain bacteria, enhancing its efficacy. Lycefoxim is administered orally and is well absorbed from the gastrointestinal tract, achieving therapeutic concentrations in blood and tissues. It is generally well tolerated; common adverse effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Hypersensitivity reactions, including rash and anaphylaxis, although rare, require immediate medical attention. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Dosage adjustments may be necessary in patients with renal impairment. Lycefoxim should be used under medical supervision, ensuring appropriate culture and sensitivity testing to optimize antibacterial therapy and reduce the risk of resistance development.